Comparative safety and effectiveness of factor-xa inhibitors vs. phenprocoumon in patients with non-valvular atrial fibrillation and diabetes

Authors :: S Kloss
H Bonnemeier
N Schmedt
D Häckl
Tatsiana Vaitsiakhovich
D Enders
Source :: Diabetes – Nicht nur eine Typ-Frage – www.diabeteskongress.de.
Publication Year :: 2019
Publisher :: Georg Thieme Verlag KG, 2019.

Subjects :: medicine.medical_specialty
medicine.drug_mechanism_of_action
business.industry
Factor Xa Inhibitor
Non valvular atrial fibrillation
Comparative safety
medicine.disease
Phenprocoumon
Diabetes mellitus
Internal medicine
medicine
Cardiology
In patient
business
medicine.drug

Full Text Access

Tools